Immune cells for BK or JC virus infections
Part of Brain & nervous system, Cancer, Immune system & allergy, Infections clinical trials.
This trial tests a treatment using special immune cells (called cytotoxic T lymphocytes) to fight BK or JC virus infections in people with weakened immune systems, such as cancer patients or organ transplant recipients. It may help control the virus and reduce related complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 2 years old.
- You have a weakened immune system due to a condition like cancer, HIV/AIDS, or an organ transplant, or you have a JC virus brain infection (PML).
- You have a BK or JC virus infection confirmed by blood, urine, or tissue tests.
- If you are taking steroids, your dose must be 6 mg or less of prednisone (or equivalent) per day.
- You cannot have certain treatments (like ATG, donor lymphocyte infusion, or alemtuzumab) within the past 14–28 days.
- You do not have uncontrolled infections or severe graft-versus-host disease (GVHD) if you had a transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving special immune cells (called cytotoxic T lymphocytes) can fight viruses like CMV, adenovirus, EBV, or BK virus that are not responding to usual treatments. It is for people aged 0 to 29 with weakened immune systems due to inherited conditions or previous transplants.
This program offers an experimental treatment for children under 18 who have had a stem cell transplant or CAR T-cell therapy and are struggling with persistent viral infections like EBV or CMV. It may help when standard treatments haven't worked.
This study tests a new, unlicensed medicine (AIC468) to see if it can reduce BK virus levels in kidney transplant patients. BK virus can sometimes harm the new kidney, so this treatment aims to lower the virus and protect the transplant.
This study tests a new treatment using lab-made antibodies to treat BK virus infection. It may help by controlling the virus in adults who already test BK positive.
This early-phase (Phase 1) study tests an immune cell treatment (R-MVST) to help people whose immune system has been weakened by a past transplant and who keep getting viral infections reactivated or not responding well to standard treatment. It may help your body control viruses like EBV, CMV, adenovirus, or BK virus.
This trial tests a special immune cell treatment (R-MVST cells) for children and young adults who have had a stem cell or organ transplant and are fighting stubborn viral infections like EBV, CMV, ADV, or BK virus. The goal is to see if these cells can help control the viruses when standard medicines haven't worked well enough.
Hear when a new Acquired Immunodeficiency Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.